| Literature DB >> 36225985 |
Min Liu1, Zhengmao Xu1, Hao Li2.
Abstract
In order to solve the effect of orthodontics combined with implant repair on the aesthetic effect and gingival crevicular fluid factor of patients with dentition defect and periodontitis, 60 patients who met the diagnostic criteria of chronic periodontitis were proposed. They were randomly divided into treatment group (taking Bushen Huoxue Guchi recipe for 3 courses while basic periodontal treatment) and control group (only basic periodontal treatment without taking any drugs). The experimental method of 30 cases in each group showed that PD, Al, and GI in the treatment group and control group decreased to varying degrees compared with those before treatment. The treatment group decreased significantly compared with the control group (P < 0.01). Chronic periodontitis is a common clinical periodontal disease, accounting for up to 95%, local stimulation, a variety of anaerobic bacteria infection, and periodontal plaque, and other factors may cause the occurrence of diseases. Routine treatment mainly includes upper gingival cleaning, lower curettage treatment, and equal root surface treatment. Although the clinical symptoms can be alleviated to a certain extent, the cause cannot be fundamentally excluded, leading to the disease progression in some patients and the formation of aggressive periodontitis and necrotizing periodontal disease.Entities:
Mesh:
Year: 2022 PMID: 36225985 PMCID: PMC9550467 DOI: 10.1155/2022/8065313
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Orthodontic treatment process.
Figure 2STL file loading.
Figure 3Transformation process.
Instruments and apparatus.
| Instrument | Company |
|---|---|
| Ultrasonic scaler | EMS, Switzerland |
| Manual curette | Shanghai Stomatological Medical Equipment Factory |
| Sampling gun | Biohit, Finland |
| Micro compounder | WH2, Shanghai ChuDing Analytical Instrument Co., Ltd |
| Pipette | Rainin, USA |
| Electronic analytical balance | Shanghai YIDA Medical Instruments Co., Ltd. |
| Ultra low temperature freezer | Zhongke Meiling |
| Freezing centrifuge | Beijing Baiyang Medical Equipment Co., Ltd. |
| Automatic microplate reader | Thermo EI ECTRON |
| Flush syringe | CORPORATION |
| Filter paper strip | Shandong Weigao Group Medical Polymer Co., Ltd. |
| EP tube | Fushun civil affairs filter paper factory |
| Periodontal probe | Eppendorf, Germany |
Reagents.
| Reagent name | Batch number | Manufacturer |
|---|---|---|
| Human interleukin-1 | 1101B6053 | Hangzhou Lianke Biotechnology Co., Ltd |
| ELISA kit | ||
|
| ||
| Human tumor necrosis factor-a | 118260921 | Hangzhou Lianke Biotechnology Co., Ltd |
| ELISA kit | ||
|
| ||
| Human matrix metalloproteinase-2 | 11M0260947 | Hangzhou Lianke Biotechnology Co., Ltd |
| ELISA kit | ||
|
| ||
| 3% hydrogen peroxide solution | 0059 | Shandong Lierkang Medical Technology Co., Ltd. |
|
| ||
| PBS buffer | 8116104 | Shanghai Lifei Biotechnology Co., Ltd. |
Comparison of gender, age, and course of disease between the treatment group and control group (n = 30).
| Group | Gender [male (%)] | Age (years) ( | Course of disease (year) (+ |
|---|---|---|---|
| Treatment group | [12 (43%)] | 51.53 ± 4.08 | 8.57 ± 0.63 |
| Control group | [15 (80%)] | 56.47 ± 3.99 | 8.67 ± 0.66 |
|
| 0.785∗ | 0.325∗ | 0.068∗ |
Comparison of GI between the treatment group and control group after 4 weeks of basic treatment (n = 30).
| Group/GI score | 0 | 1 | 2 | 3 |
|---|---|---|---|---|
| Treatment group (number of cases) | 1 | 18 | 10 | 1 |
| Control group (number of cases) | 0 | 11 | 20 | 0 |
Comparison of Al between treatment group and control group (x + s) (n = 30).
| Group/time | 1 week | 4 weeks |
|
|
|---|---|---|---|---|
| Treatment group | 2.97 ± 0.72 | 1.47 ± 0.67 | 53.254∗∗∗ | <0.001∗∗∗ |
| Control group | 3.17 ± 0.78 | 2.45 ± 0.68 | 20.905∗∗∗∗ | <0.002∗∗∗∗ |
|
| 1.235∗ | 2.87.69∗∗ | — | — |
|
| 0.259∗ | <0.002∗∗ | — | — |
IL-1 in the treatment group and control group β Comparison of (PG/ml) (x + s) (n = 30).
| Group/time | 1 week | 4 weeks |
|
|
|---|---|---|---|---|
| Treatment group | 694.09 ± 56.98 | 275.60 ± 42.09 | 653.97∗∗ | <0.001∗∗∗ |
| Control group | 657.60 ± 60.48 | 374.79 ± 49.77 | 338.895∗∗∗ | <0.001∗∗∗∗ |
|
| 0.161∗ | 635.89∗∗ | — | — |
|
| 0.977∗ | <0.001∗∗ | — | — |
Comparison of MMP-2 between the treatment group and control group (PG / ml) (x + s) (n = 30).
| Group / time | 1 week | 4 weeks |
|
|
|---|---|---|---|---|
| Treatment group | 139.21 ± 28.17 | 64.96 ± 20.46 | 154.076∗∗∗ | <0.001∗∗∗ |
| Control group | 129.31 ± 24.93 | 87.87 ± 15.43 | 54.778∗∗∗∗ | <0.001∗∗∗∗ |
|
| 0.187∗ | 916.978∗∗ | — | — |
|
| 0.658∗ | <0.001∗∗∗ | — | — |
Figure 4Comparison of GI at baseline between the treatment group and control group.